Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Clinical trial NCT01402440 · TERMINATED
Trial details
- NCT number
- NCT01402440
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2014-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.